Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-19T08:32:43.506Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroleptic Malignant Syndrome and Lethal Catatonia

Published online by Cambridge University Press:  29 January 2018

James Lindesay
James Lindesay*
Affiliation:
UMDS (Guy's Campus), London Bridge, London SE1 9RT
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 148 , Issue 3 , March 1986 , pp. 342 - 343
Copyright
Copyright © 1986 The Royal College of Psychiatrists 

References

Allan, R. N. & White, H. C. (1972) Side effects of parenteral long-acting phenothiazines. British Medical Journal, i, 221.Google Scholar
Arnold, O. H. & Stepan, H. (1952) Research on the problem of acute lethal catatonia. Weiner Zeitschrift Nervenheilk, 4, 235–237.Google Scholar
Burke, R. E., Fahn, S., Mayeux, R., Weinberg, H., Louis, K., & Willner, J. H. (1981) Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntingdon disease. Neurology (NY), 31, 1022–1026.Google Scholar
Coons, D. J., Hillman, F. J. & Marshall, R. W. (1982) Treatment of neuroleptic malignant with dantrolene sodium: a case report. American Journal of Psychiatry, 139, 944–945.Google Scholar
Peele, R. & Von Loetzen, I. S. (1973) Phenothiazine deaths: a critical review. American Journal of Psychiatry, 130, 306–309.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.